Schubert & CO Viatris Inc Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$8.72 - $11.56 $156 - $208	-18 Reduced 6.19%	273 $3,000
Q3 2022 Oct 21, 2022	SELL	$8.48 - $11.13 $703 - $923	-83 Reduced 22.19%	291 $2,000
Q2 2022 Aug 01, 2022	BUY	$9.95 - $12.27 $945 - $1,165	95 Added 34.05%	374 $4,000
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $1,569 - $2,464	-160 Reduced 36.45%	279 $3,000
Q4 2021 Jan 28, 2022	BUY	$12.09 - $14.68 $5,307 - $6,444	439 New	439 $6,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.5B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.